News | January 06, 2026
Nia Therapeutics unveils first implantable brain interface for memory disorders
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Effectiveness of Covaxin against the Omicron variant is currently being studied
The conference highlighted research suggesting that deuterium levels may influence key biological processes
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
Subscribe To Our Newsletter & Stay Updated
